Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$75.55 - $92.52 $1,888 - $2,313
25 New
25 $2,000
Q1 2022

May 12, 2022

SELL
$80.11 - $90.62 $4,005 - $4,531
-50 Closed
0 $0
Q3 2021

Nov 03, 2021

SELL
$81.78 - $95.14 $6,133 - $7,135
-75 Reduced 60.0%
50 $4,000
Q4 2020

Feb 02, 2021

BUY
$78.07 - $94.43 $5,855 - $7,082
75 Added 150.0%
125 $12,000
Q2 2020

Jul 23, 2020

SELL
$80.93 - $91.1 $10,116 - $11,387
-125 Reduced 71.43%
50 $4,000
Q3 2019

Oct 31, 2019

SELL
$85.54 - $94.26 $4,277 - $4,713
-50 Reduced 22.22%
175 $15,000
Q4 2018

Feb 08, 2019

SELL
$73.66 - $82.02 $9,207 - $10,252
-125 Reduced 35.71%
225 $19,000
Q3 2018

Oct 22, 2018

BUY
$66.94 - $77.43 $20,082 - $23,229
300 Added 600.0%
350 $30,000
Q3 2017

Oct 26, 2017

BUY
$74.14 - $77.27 $3,707 - $3,863
50
50 $4,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $216B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Delta Asset Management LLC Portfolio

Follow Delta Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Asset Management LLC with notifications on news.